ABC News logo
Associated Press logo
The Independent logo
24 articles
·7M

Biden Administration Proposes $35 Billion Coverage for Anti-Obesity Drugs Amid Challenges from Incoming Trump Officials

The Biden administration's rule seeks to allow Medicare and Medicaid coverage for anti-obesity medications, but faces potential opposition and budget concerns.

Overview

A summary of the key points of this story verified across multiple sources.

On November 26, 2024, the Biden administration proposed a $35 billion plan to cover anti-obesity drugs like Wegovy and Zepbound under Medicare and Medicaid, potentially benefiting millions. However, the rule, requiring Congressional approval, faces skepticism from incoming Trump administration officials, particularly Robert F. Kennedy Jr., who opposes the drugs. While a bipartisan coalition supports the initiative, concerns regarding its high cost and the necessity of price negotiations with manufacturers persist among some lawmakers.

Content generated by AI—learn more or report issue.

Pano Newsletter

Get both sides in 5 minutes with our daily newsletter.

Analysis

Compare how each side frames the story — including which facts they emphasize or leave out.

Analysis unavailable for this viewpoint.

Articles (24)

Compare how different news outlets are covering this story.

Center (13)

No highlight available for this article.

Biden proposes anti-obesity drug rule
The HillThe Hill·7M·
Center
This outlet is balanced or reflects centrist views.

History

See how this story has evolved over time.

  • 7M
    PBS NewsHour logo
    ABC News logo
    Roll Call logo
    4 articles
  • 7M
    ABC News logo
    NBC News logo
    CNN logo
    4 articles